Clinical trial
Evaluation of Duodenal Mucosal Resurfacing for the Treatment of Type 2 Diabetes
NCT02413567 is registered in ClinicalTrials.gov with Fractyl Health Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Duodenal Mucosal Resurfacing for the Treatment of Type 2 Diabetes
- Lead sponsor
- Fractyl Health Inc.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 23, 2015
- Completion date
- September 18, 2019
- Enrollment
- 60 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.